Physician profile
John Terry Dearborn
NPI 1396786901
$2,454,479.45
in general payments reported to CMS, 2019-2025
5 companies · $2,980 in 2025
The $2,980 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,452 · 2020: $51K · 2021: $161K · 2022: $272K · 2023: $360K · 2024: $1.6M · 2025: $2,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.0M · Travel and Lodging: $3,758 · Food and Beverage: $1,691 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,957,263.34 |
| Travel and Lodging | $3,757.74 |
| Food and Beverage | $1,690.62 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,443,455.39 | 2019-2025 | Avenir, Rosa, Oxford |
| Techmah Medical, LLC | $10,672.86 | 2020 | |
| Lima USA, INC. | $309.61 | 2020 | |
| Heron Therapeutics, INC. | $23.69 | 2022 | |
| Medtronic, INC. | $17.90 | 2023 | Swiftset |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dearborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.